Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

International Hypoglycaemia Study Group

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)
181 Downloads (Pure)
Original languageEnglish
Publication statusPublished - 21 Nov 2016

Cite this